MeVis Medical Solutions AG (LTS:0HI7) 3-Year EBITDA Growth Rate : -4.70% (As of Sep. 2023)

View and export this data going back to 2014. Start your Free Trial

What is MeVis Medical Solutions AG 3-Year EBITDA Growth Rate?

MeVis Medical Solutions AG's EBITDA per Share for the six months ended in Sep. 2023 was €1.78.

During the past 12 months, MeVis Medical Solutions AG's average EBITDA Per Share Growth Rate was -35.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -4.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -7.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of MeVis Medical Solutions AG was 23.70% per year. The lowest was -32.00% per year. And the median was 4.25% per year.

Competitive Comparison of MeVis Medical Solutions AG's 3-Year EBITDA Growth Rate

For the Health Information Services subindustry, MeVis Medical Solutions AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MeVis Medical Solutions AG's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where MeVis Medical Solutions AG's 3-Year EBITDA Growth Rate falls into.

MeVis Medical Solutions AG 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

MeVis Medical Solutions AG (LTS:0HI7) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

MeVis Medical Solutions AG 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of MeVis Medical Solutions AG's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

MeVis Medical Solutions AG (LTS:0HI7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MeVis Medical Solutions AG (LTS:0HI7) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

M3V:Germany

Address

Caroline-Herschel-Strasse 1, Bremen, DEU, 28359

Website

http://www.mevis.de

MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.

MeVis Medical Solutions AG (LTS:0HI7) Headlines

No Headlines